Cord Blood Transplant in Adults With Blood Cancers
Status:
Recruiting
Trial end date:
2028-05-22
Target enrollment:
Participant gender:
Summary
Cord blood transplants (CBT) are a standard treatment for adults with blood cancers. MSK has
developed a standard ("optimized") practice for cord blood transplant (CBT). This optimized
practice includes how patients are evaluated for transplant, the conditioning treatment
(standard chemotherapy and total body irradiation therapy) given to prepare the body for
transplant, the amount of stem cells transplanted, and how patients are followed during and
after transplant.The purpose of this study is to collect information about participant
outcomes after CBT following MSK's optimized practice. The researchers will look at outcomes
of the CBT treatment such as side effects, disease relapse, GVHD, and immune system recovery
after CBT treatment.